David Low
Stock Analyst at UBS
(3.54)
# 2,258
Out of 4,969 analysts
304
Total ratings
52.6%
Success rate
5.1%
Average return
Main Sectors:
Stocks Rated by David Low
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: REG Regis Healthcare Limited | Maintained: Hold | $6.75 → $5.95 | $4.30 | +38.37% | 16 | Sep 3, 2026 | |
| ASX: CSL CSL Limited | Maintained: Buy | $181.00 | $175.50 | +3.13% | 32 | Sep 2, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Maintained: Hold | $42.90 → $55.60 | $51.80 | +7.34% | 21 | Aug 28, 2026 | |
| ASX: ANN Ansell Limited | Maintained: Hold | $34.25 → $38.70 | $42.30 | -8.51% | 17 | Aug 25, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Maintained: Hold | $19.60 → $21.20 | $19.30 | +9.84% | 33 | Aug 21, 2026 | |
| ASX: COH Cochlear Limited | Maintained: Hold | $106.00 → $150.00 | $140.97 | +6.41% | 22 | Aug 19, 2026 | |
| ASX: RMD ResMed Inc. | Maintained: Buy | n/a | $32.09 | - | 25 | Aug 7, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Downgraded: Hold | $16.50 | $16.26 | n/a | 3 | Aug 31, 2025 | |
| ASX: PNV PolyNovo Limited | Maintained: Hold | $1.30 | $1.02 | n/a | 1 | Aug 27, 2025 | |
| NZE: EBO EBOS Group Limited | Maintained: Hold | $47.09 → $44.64 | $20.70 | n/a | 3 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $4.00 → $3.90 | $2.75 | n/a | 20 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.25 → $3.40 | $2.28 | n/a | 12 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $0.62 | $0.46 | n/a | 26 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $282.00 → $300.00 | $172.70 | n/a | 5 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $290 → $310 | $230.87 | n/a | 43 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 32.00 → 35.00 | 44.29 | n/a | 13 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.95 → $0.78 | $0.30 | n/a | 4 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.43 | n/a | 7 | Aug 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $31.30 | n/a | 1 | Dec 4, 2019 |
Regis Healthcare Limited
Sep 3, 2026
Maintained: Hold
Price Target: $6.75 → $5.95
Current: $4.30
Upside: +38.37%
CSL Limited
Sep 2, 2026
Maintained: Buy
Price Target: $181.00
Current: $175.50
Upside: +3.13%
Ramsay Health Care Limited
Aug 28, 2026
Maintained: Hold
Price Target: $42.90 → $55.60
Current: $51.80
Upside: +7.34%
Ansell Limited
Aug 25, 2026
Maintained: Hold
Price Target: $34.25 → $38.70
Current: $42.30
Upside: -8.51%
Sonic Healthcare Limited
Aug 21, 2026
Maintained: Hold
Price Target: $19.60 → $21.20
Current: $19.30
Upside: +9.84%
Cochlear Limited
Aug 19, 2026
Maintained: Hold
Price Target: $106.00 → $150.00
Current: $140.97
Upside: +6.41%
ResMed Inc.
Aug 7, 2026
Maintained: Buy
Price Target: n/a
Current: $32.09
Upside: -
Telix Pharmaceuticals Limited
Aug 31, 2025
Downgraded: Hold
Price Target: $16.50
Current: $16.26
Upside: n/a
PolyNovo Limited
Aug 27, 2025
Maintained: Hold
Price Target: $1.30
Current: $1.02
Upside: n/a
EBOS Group Limited
Aug 27, 2025
Maintained: Hold
Price Target: $47.09 → $44.64
Current: $20.70
Upside: n/a
Aug 27, 2025
Maintained: Sell
Price Target: $4.00 → $3.90
Current: $2.75
Upside: n/a
Aug 27, 2025
Maintained: Buy
Price Target: $3.25 → $3.40
Current: $2.28
Upside: n/a
Aug 25, 2025
Maintained: Sell
Price Target: $0.62
Current: $0.46
Upside: n/a
Aug 14, 2025
Maintained: Hold
Price Target: $282.00 → $300.00
Current: $172.70
Upside: n/a
Aug 1, 2025
Maintained: Buy
Price Target: $290 → $310
Current: $230.87
Upside: n/a
Jun 3, 2025
Maintained: Hold
Price Target: 32.00 → 35.00
Current: 44.29
Upside: n/a
Mar 2, 2025
Maintained: Buy
Price Target: $0.95 → $0.78
Current: $0.30
Upside: n/a
Aug 23, 2021
Maintained: Hold
Price Target: n/a
Current: $13.43
Upside: n/a
Dec 4, 2019
Downgraded: Hold
Price Target: n/a
Current: $31.30
Upside: n/a